J. Li

Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

E. Van Cutsem, R. Mayer, N. Amellal, 2022, ESMO open.

Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas

J. Gong, Y. Li, X. Zhang, 2013, Medical Oncology.

Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies

N. Xu, L. Shen, W. Lou, 2022, ESMO open.

Efficacy and safety of PD-1 blockade with JS001 in patients with advanced neuroendocrine neoplasms: A non-randomized, open-label, phase Ib trial.

L. Shen, M. Lu, P. Zhang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[A clinico-pathologic study of primary malignant fibrous histiocytoma of bone].

L. Shen, P. Liu, J. Li, 1996, Zhonghua zhong liu za zhi [Chinese journal of oncology].

Adjuvant therapy with imatinib in gastrointestinal stromal tumor (GIST) patients with intermediate or high risk: Analysis from a single-center contrast study.

L. Shen, W. Wu, J. Li, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Advances in radiological studies of gastrointestinal stromal tumors].

L. Tang, J. Li, 2019, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

bMSI better predicts the responses to immune checkpoint inhibitors (ICI) than MMR/MSI from historical tissue specimens in metastatic gastrointestinal cancer patients.

M. Wang, J. Gong, S. Cai, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.